To volunteer in any of the clinicial trial research studies listed below, please click here
To learn more about each of the clinical research studies, please contact the recruiter for each study. The complete contact information of the recruiters can be found here.
**Monetary compesation for time and travel for participating in the studies varies, but typically ranges from $25-75 per study visit.**
HVTN 119 A clinical research study being conducted to determine the safety and effectiveness of an investigational vaccine for the prevention of HIV. You may qualify if you are a healthy adult between the ages of 18 - 50 and are HIV negative. To participate, contact April Ross at firstname.lastname@example.org or call 404-712-9493.
Norovirus Study is being done to determine the safety and tolerability of the Snow Mountain Virus (SMV) and the number of norovirus particles needed to make a person sick. We are looking for healthy adults, 18-49, who are willing and available to be in the hospital for 5 days. Noroviruses are the most common cause of gastroenteritis (stomach flu). You will be hospitalized for 5 days and have 4 follow-up visits and one phone call at 6 months. Compensation is $50 for initial screening, $200 per hospital day, $75 for follow up visits. If interested please call Eileen Osinski at 404-712-1371 or email at email@example.com.
VAX2 004 A Chicken Pox Vaccine Immunology clinical research study. We are looking for healthy volunteers over the age of 18 with proof of prior chicken pox vaccination. The study involves 1 to 2 clinic visits, blood draw and an optional bone marrow aspiration. You will be compensated for time and travel. If interested please call Eileen Osinski at 404-712-1371 or email at firstname.lastname@example.org.
Yellow Fever Studies A clinical trial research study investigating the yellow fever vaccine. Adults who have never had the yellow fever vaccine can participate in the study. Participants need to be between the ages of 18-45 years of age. To participate, contact the Study Coordinator, Ms. Eileen Osinki at email@example.com
083 Study A clinical research trial to determine whether a new drug, called Cabotegravir (CAB) is safe and effective in protecting against HIV among non-HIV infected adults at risk of HIV-infection. To learn more, click here. Particpants must be 18 years or older to participate. Contact the Study Coordinator Rameses Ferederick for more information firstname.lastname@example.org.
Prep 2 Study A new clinical research trial for HIV prevention among non-HIV infected adults at risk of HIV-infection. You may be eligible to participate in a Prep agent HIV prevention research study. To participate, contact the study coordinator Rameses Frederick for more information email@example.com.
AMP Study: Antibody Mediated Study A clinical trial research study to investigate the usefulness of an antibody to prevent HIV among non-HIV infected adults at risk of HIV-infection. To learn more, click here. To participate, contact our recruiters, Ms. April Ross or Mr. Rameses Frederick at firstname.lastname@example.org or email@example.com.
Cdiff study: Cdiffense Clostridium Difficile Vaccine Trial. A clinical trial research study to investigate a vaccine against the clostridium difficile "C. diff" among adults age 50 years or order. C Diff is a disease common among recently hospitalized individuals, particularly those of older age. To participate, contact April Ross at firstname.lastname@example.org
Zika Natural History Study A clinical trial research study to better understand the effects of the Zika virus on the body. This information can be used to help develop a vaccine as well as better diagnostic and therapeutic tools in the future. No treatment or drugs will be given in this study. Volunteers with suspected or confirmed zika virus infection are needed for to participate in this study. To participate, contact email@example.com or call 404-712-1370.
HVTN 910 A clinical trial to assess the persistance of HIV vaccine-induced seropositivity (VISP) in participants who received a vaccine in a DAIDS funded preventive HIV vaccine trial. This study allows participants to have two HIV tests per year until they have three consecutive test results that show no vaccine-induced antibodies to HIV. To participate contact firstname.lastname@example.org or call 404-712-1370.
ARM Study A clinical research study to better understand rectal HIV transmission in gay and bisexual men among the ages of 18-19 or 35 and older. Participant must be willing to undergo a rectal sampling and can not be currently taking prep. For more information contact Jasper Barnes email@example.com or call 404-712-9071.
Janssen Study 118 (Closed) A clinical research study being conducted to determine the safety and effectiveness of an investigational vaccine for the prevention of HIV. You may qualify if you are a healthy adult between the ages of 18 - 50 and are HIV negative. To participate, contact April Ross at firstname.lastname@example.org or call 404-712-9493.
Micro Biome Study (Closed)A new clincial trial research study in need of volunteers who are willing to donate a stool sample. You must be in good health and between the ages of 18-23 or 60 and above. This research study involves 1-2 clinic visits and you are compensated for your participation. For more information please contact April Ross at email@example.com.
Influenza Heavy Water Study (Closed) A clinical trial research study to investigate the immune responses to the seasonal flu vaccine and to track the responses using a special water called heavy water. Participants must be between the ages of 18-45 and can not have had the flu shot in the past three years. Contact April Ross firstname.lastname@example.org for more information.